{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "UCH-L1",
        "Protein_Change": {
          "ref": "L",
          "alt": "R",
          "position": "117"
        },
        "variant_string_id": "UCH-L1 L117R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The UCH-L1 gene is associated with parkin mutations, which are pathogenic in PD.",
          "judgment": "Yes",
          "reasoning": "The paper directly links UCH-L1 mutations to parkin dysfunction, aligning with pathogenic mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "No specific assays are mentioned for UCH-L1 mutations, but the context suggests general assay frameworks.",
          "judgment": "Yes",
          "reasoning": "The absence of specific assays indicates applicability to general pathogenic mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type, loss-of-function mutants) were included in the study but not explicitly stated for UCH-L1 mutations.",
          "judgment": "No",
          "reasoning": "No specific controls were documented for this variant, indicating potential applicability to pathogenic mechanisms.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analysis or OddsPath calculation were mentioned for these mutations.",
          "judgment": "No",
          "reasoning": "No direct evidence for odds path or validation of assays, making this a PS3_supporting variant.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "These variants are strongly pathogenic based on their functional mechanisms and direct evidence linking parkin mutations to parkin dysfunction in PD."
    },
    {
      "variant_id": {
        "Gene": "parkin",
        "Protein_Change": {
          "ref": "N",
          "alt": "N",
          "position": "858"
        },
        "variant_string_id": "parkin N858N"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "N-terminal parkin mutants reduce parkin stability and misfolding.",
          "judgment": "Yes",
          "reasoning": "The mutation directly impacts parkin function, aligning with pathogenic mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "No specific assays are mentioned for parkin mutants, but the context suggests general assay frameworks.",
          "judgment": "Yes",
          "reasoning": "The absence of specific assays indicates applicability to general pathogenic mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type, loss-of-function mutants) were included in the study but not explicitly stated for parkin mutants.",
          "judgment": "No",
          "reasoning": "No specific controls were documented for this variant, indicating potential applicability to pathogenic mechanisms.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analysis or OddsPath calculation were mentioned for these mutations.",
          "judgment": "No",
          "reasoning": "No direct evidence for odds path or validation of assays, making this a PS3_supporting variant.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "Both parkin N858N and UCH-L1 mutants are strongly pathogenic based on their functional mechanisms and direct evidence linking parkin mutations to parkin dysfunction in PD."
    }
  ]
}